Literature DB >> 15801916

Missing gastric cancer in dyspepsia.

N Schmidt1, U Peitz, H Lippert, P Malfertheiner.   

Abstract

BACKGROUND: Dyspepsia is common in gastric cancer, but also in many benign conditions. European Helicobacter pylori Study Group and American Gastroenterological Association guidelines recommend endoscopy in dyspepsia for patients with alarm symptoms or at age >45 years. However, recommendations are controversial. AIM: To investigate whether criteria for endoscopy in patients with dyspepsia are adequate to detect gastric cancer.
METHODS: In 215 patients at initial diagnosis of gastric adenocarcinoma, symptoms were classified as alarm and non-alarm. Cases were staged according to the TNM system. Stages T(1)-T(3)N(x)M(0) were defined as potentially curable.
RESULTS: Dyspepsia was present in 128 patients. Among patients with dyspepsia, 15 were < or =45 years and 41 denied alarm symptoms. The combination of both criteria excluded only three (2.3%) patients from endoscopy, but increasing the threshold to >50 and >55 years would have raised the rate of excluded patients to seven (5.5%) and 11 (8.6%). Only 53 potentially curable stages and 18 early gastric cancers occurred, but the tumour stage was not associated with dyspepsia duration, age threshold of 45 years, or alarm symptoms.
CONCLUSIONS: Our results support current European Helicobacter Study Group and American Gastroenterological Association criteria for endoscopy in patients with dyspepsia to detect gastric cancer. Regardless, most cancers are advanced at detection.

Entities:  

Mesh:

Year:  2005        PMID: 15801916     DOI: 10.1111/j.1365-2036.2005.02425.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  11 in total

Review 1.  Gastric carcinogenesis.

Authors:  Jan Bornschein; Peter Malfertheiner
Journal:  Langenbecks Arch Surg       Date:  2011-05-25       Impact factor: 3.445

2.  Interference of P-REX2a may inhibit proliferation and reverse the resistance of SGC7901 cells to doxorubicin.

Authors:  Yaowei Ai; Qiaohui Zhou; Ling Li; Zhihong Pan; Mingwen Guo; Jingbo Han
Journal:  Oncol Lett       Date:  2017-12-27       Impact factor: 2.967

3.  Upper gastrointestinal cancer in its early stages is predominantly asymptomatic.

Authors:  James W Berrill; Jeff K Turner; Jo J Hurley; Gillian Swift; Sunil Dolwani; John T Green
Journal:  Frontline Gastroenterol       Date:  2011-09-10

Review 4.  Helicobacter pylori in gastric carcinogenesis.

Authors:  Hyo Jun Ahn; Dong Soo Lee
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

Review 5.  Gastric cancer: prevention, screening and early diagnosis.

Authors:  Victor Pasechnikov; Sergej Chukov; Evgeny Fedorov; Ilze Kikuste; Marcis Leja
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

6.  Clinicopathological profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients.

Authors:  Jan Kulig; Tadeusz Popiela; Piotr Kolodziejczyk; Marek Sierzega; Joanna Jedrys; Antoni M Szczepanik
Journal:  Langenbecks Arch Surg       Date:  2007-07-06       Impact factor: 3.445

Review 7.  Role of symptoms in diagnosis and outcome of gastric cancer.

Authors:  Giovanni Maconi; Gianpiero Manes; Gabriele-Bianchi Porro
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

8.  Serological assessment of gastric mucosal atrophy in gastric cancer.

Authors:  Jan Bornschein; Michael Selgrad; Thomas Wex; Doerthe Kuester; Peter Malfertheiner
Journal:  BMC Gastroenterol       Date:  2012-01-31       Impact factor: 3.067

9.  Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial.

Authors:  Seung Tae Kim; Jason K Sa; Sung Yong Oh; Kyung Kim; Jung Yong Hong; Won Ki Kang; Kyoung-Mee Kim; Jeeyun Lee
Journal:  Genome Med       Date:  2021-01-25       Impact factor: 11.117

Review 10.  Current status of functional dyspepsia in Korea.

Authors:  Hyuk Lee; Hye-Kyung Jung; Kyu Chan Huh
Journal:  Korean J Intern Med       Date:  2014-02-27       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.